InMode Defends Its Feminine Rejuvenation Patent Against BTL Industries' Review Request
InMode Defends Its Feminine Rejuvenation Patent Against BTL Industries' Review Request
InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, responded to the recent petition to the U.S. Patent & Trademark Office filed by BTL Industries, Inc., in which BTL asks the USPTO to conduct an Inter Partes Review of InMode's U.S. Patent No. 8,961,511. Six months before BTL's petition, InMode sued BTL in the United States District Court for the Central District of California alleging that BTL's UltraFemme 360 and EmFemme 360 non-invasive, radio-frequency based feminine rejuvenation products infringe the patent. That litigation is ongoing.
全球领先的创新医疗技术提供商InMode有限公司（纳斯达克股票代码：INMD）回应了BTL工业公司最近向美国专利商标局提交的请愿书，其中BTL要求美国专利商标局对InMode的美国专利号8,961,511进行各方间审查。在BTL提出请愿前六个月，InMode在美国加利福尼亚中区地方法院起诉了BTL，指控BTL的UltraFemme 360和EmFemme 360非侵入性、基于射频的女性嫩肤产品侵犯了该专利。该诉讼仍在进行中。